These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 31030372)
1. Predictive Value of Microdose Pharmacokinetics. van Nuland M; Rosing H; Huitema ADR; Beijnen JH Clin Pharmacokinet; 2019 Oct; 58(10):1221-1236. PubMed ID: 31030372 [TBL] [Abstract][Full Text] [Related]
2. Pilot Study to Predict Pharmacokinetics of a Therapeutic Gemcitabine Dose From a Microdose. Van Nuland M; Rosing H; Thijssen B; Burgers JA; Huitema ADR; Marchetti S; Schellens JHM; Beijnen JH Clin Pharmacol Drug Dev; 2020 Nov; 9(8):929-937. PubMed ID: 31970932 [TBL] [Abstract][Full Text] [Related]
3. Novel strategies for microdose studies using non-radiolabeled compounds. Maeda K; Sugiyama Y Adv Drug Deliv Rev; 2011 Jun; 63(7):532-8. PubMed ID: 21345359 [TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers. Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Brian Houston J; Oosterhuis B; Bjerrum OJ; Grynkiewicz G; Alder J; Rowland M; Garner C Eur J Pharm Sci; 2011 Jun; 43(3):141-50. PubMed ID: 21540108 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry. Balani SK; Nagaraja NV; Qian MG; Costa AO; Daniels JS; Yang H; Shimoga PR; Wu JT; Gan LS; Lee FW; Miwa GT Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814 [TBL] [Abstract][Full Text] [Related]
6. A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimens. van der Heijden L; van Nuland M; Beijnen J; Huitema A; Dorlo T Clin Transl Sci; 2023 Feb; 16(2):258-268. PubMed ID: 36419385 [TBL] [Abstract][Full Text] [Related]
7. To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics. Bosgra S; Vlaming ML; Vaes WH Clin Pharmacokinet; 2016 Jan; 55(1):1-15. PubMed ID: 26242381 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability. Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Houston B; Oosterhuis B; Bjerrum OJ; Rowland M; Garner C Eur J Pharm Sci; 2010 May; 40(2):125-31. PubMed ID: 20307657 [TBL] [Abstract][Full Text] [Related]
9. Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS. Yamazaki A; Kumagai Y; Yamane N; Tozuka Z; Sugiyama Y; Fujita T; Yokota S; Maeda M J Clin Pharm Ther; 2010 Apr; 35(2):169-75. PubMed ID: 20456735 [TBL] [Abstract][Full Text] [Related]
10. Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data. Garner RC Bioanalysis; 2010 Mar; 2(3):429-40. PubMed ID: 21083253 [TBL] [Abstract][Full Text] [Related]
11. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140 [TBL] [Abstract][Full Text] [Related]
12. A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer. Fujita K; Yoshino E; Kawara K; Maeda K; Kusuhara H; Sugiyama Y; Yokoyama T; Kaneta T; Ishida H; Sasaki Y Cancer Chemother Pharmacol; 2015 Oct; 76(4):793-801. PubMed ID: 26297058 [TBL] [Abstract][Full Text] [Related]
13. Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis. Garner CR; Park KB; French NS; Earnshaw C; Schipani A; Selby AM; Byrne L; Siner S; Crawley FP; Vaes WH; van Duijn E; deLigt R; Varendi H; Lass J; Grynkiewicz G; Maruszak W; Turner MA Br J Clin Pharmacol; 2015 Jul; 80(1):157-67. PubMed ID: 25619398 [TBL] [Abstract][Full Text] [Related]
14. The utility of microdosing over the past 5 years. Lappin G; Garner RC Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1499-506. PubMed ID: 19040326 [TBL] [Abstract][Full Text] [Related]
15. Nonlinear pharmacokinetics of oral quinidine and verapamil in healthy subjects: a clinical microdosing study. Maeda K; Takano J; Ikeda Y; Fujita T; Oyama Y; Nozawa K; Kumagai Y; Sugiyama Y Clin Pharmacol Ther; 2011 Aug; 90(2):263-70. PubMed ID: 21716273 [TBL] [Abstract][Full Text] [Related]
16. Microdosing and drug development: past, present and future. Lappin G; Noveck R; Burt T Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):817-34. PubMed ID: 23550938 [TBL] [Abstract][Full Text] [Related]
17. Microdose pharmacogenetic study of ¹⁴C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9∗3 on its pharmacokinetics and metabolism. Ikeda T; Aoyama S; Tozuka Z; Nozawa K; Hamabe Y; Matsui T; Kainuma M; Hasegawa S; Maeda K; Sugiyama Y Eur J Pharm Sci; 2013 Jul; 49(4):642-8. PubMed ID: 23727057 [TBL] [Abstract][Full Text] [Related]
18. Targeting intestinal transporters for optimizing oral drug absorption. Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135 [TBL] [Abstract][Full Text] [Related]
19. Approaches using molecular imaging technology -- use of PET in clinical microdose studies. Wagner CC; Langer O Adv Drug Deliv Rev; 2011 Jun; 63(7):539-46. PubMed ID: 20887762 [TBL] [Abstract][Full Text] [Related]